Tag:
AVL-292
Latest Headlines
Latest Headlines
UPDATED: Celgene snaps up Avila Therapeutics in $925M buyout
In less than five years Avila Therapeutics nailed down a reputation as an exciting developer of covalent drugs, with a lead Btk inhibitor for cancer garnering attention at a very early stage of
